Company / Profit Margin
C4 Therapeutics, Inc. Profit Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-292.1%
FY2025
5-year range
-638.3% / -183.2%
FY2022-FY2025
Trend
+54.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -638.3% to -292.1% over the past 2 years.
Based on SEC 10-K filings.
-292.1% in FY2025 with a 3-year CAGR of -108.8%.
Improved from -638.3% to -292.1% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -108.8pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 54.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -292.1% | +54.2% |
| FY2024 | -638.3% | +0.0% |
| FY2023 | -638.3% | -248.4% |
| FY2022 | -183.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026